ARTICLE | Company News
Novalar, The Forsyth Institute deal
July 30, 2007 7:00 AM UTC
Novalar received an exclusive, worldwide license to develop and commercialize the institute's clindamycin-EVA to prevent pain and bacterial infection in endodontic treatment. The antibiotic-impregnate...